Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 8 July 2024
Accepted: 12 July 2024
First Online: 24 July 2024
Declarations
:
: C-EL received lecture fees from Merck, Aerogen and AdvanzPharma, and grant from Eumedica and Merck, all outside the submitted work. MG has no conflict of interest to declare in relationship to this manuscript. PP received lecture fees from Merck and Pfizer, outside the submitted work.
Free to read: This content has been made available to all.
